Spred2 inhibits tgf-beta 1-induced urokinase type plasminogen activator expression, cell motility and epithelial mesenchymal transition

dc.date.accessioned2016-12-05T17:39:41Z
dc.date.available2016-12-05T17:39:41Z
dc.date.created2016-12-05T17:39:41Z
dc.date.issued2010
dc.identifier0020-7136
dc.identifierhttp://hdl.handle.net/10533/143537
dc.identifier1050476
dc.identifierWOS:000278148800008
dc.languageeng
dc.publisherJOHN WILEY & SONS INC
dc.relationhttps://doi.org/10.1002/ijc.25045
dc.relation10.1002/ijc.25045
dc.relationinfo:eu-repo/grantAgreement/Fondecyt/1050476
dc.relationinfo:eu-repo/semantics/dataset/hdl.handle.net/10533/93477
dc.relationinstname: Conicyt
dc.relationreponame: Repositorio Digital RI2.0
dc.relationinstname: Conicyt
dc.relationreponame: Repositorio Digital RI2.0
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleSpred2 inhibits tgf-beta 1-induced urokinase type plasminogen activator expression, cell motility and epithelial mesenchymal transition
dc.typeArticulo


Este ítem pertenece a la siguiente institución